Your browser doesn't support javascript.
loading
No Difference on Adherence Between Immediate-Release Versus Extended-Release Dopamine Agonists in Uninsured Subjects with Parkinson's Disease.
Bazán-Rodríguez, Lisette; Cervantes-Arriaga, Amin; Llorens-Arenas, Rodrigo; Calderón-Fajardo, Humberto; Rodríguez-Violante, Mayela.
Afiliação
  • Bazán-Rodríguez L; Neurodegenerative Disease Clinical Research Unit National Institute of Neurology and Neurosurgery Mexico City Mexico.
  • Cervantes-Arriaga A; Neurodegenerative Disease Clinical Research Unit National Institute of Neurology and Neurosurgery Mexico City Mexico.
  • Llorens-Arenas R; Neurodegenerative Disease Clinical Research Unit National Institute of Neurology and Neurosurgery Mexico City Mexico.
  • Calderón-Fajardo H; Movement Disorder Clinic National Institute of Neurology and Neurosurgery Mexico City Mexico.
  • Rodríguez-Violante M; Neurodegenerative Disease Clinical Research Unit National Institute of Neurology and Neurosurgery Mexico City Mexico.
Mov Disord Clin Pract ; 3(1): 68-72, 2016.
Article em En | MEDLINE | ID: mdl-30363523

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Mov Disord Clin Pract Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Mov Disord Clin Pract Ano de publicação: 2016 Tipo de documento: Article